A0A3F2ZS81 (A0A3F2ZS81_CLOB6) Clostridium botulinum (strain 657 / Type Ba4)
Hemagglutinin component HA17 UniProtKBProtein AtlasInterProInteractive Modelling
146 aa; Sequence (Fasta) ;
3 identical sequences: Clostridium botulinum: A5HZZ5, Q45878; Clostridium botulinum CFSAN001627: M1ZNV3
It is possible new templates exist for this target since these models were created.
Available Structures
9 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Apo HA17-HA33 |
Heteromer Q45871; Q45878; | 100 | ||||
| Crystal structure of HA17-HA33-IPT |
Heteromer Q45871; Q45878; | 100 | 2×IPT; | |||
| HA17-HA33-LacNac |
Heteromer Q45871; Q45878; | 100 | 2×NDG; | |||
| HA17-HA33-Lac |
Heteromer Q45871; Q45878; | 100 | 2×BGC; | |||
| HA17-HA33-Gal |
Heteromer Q45871; Q45878; | 100 | 2×GAL; | |||
| Crystal structure of HA17-HA33-Lactulose |
Heteromer Q45871; Q45878; | 100 | 2×FRU; | |||
| Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex |
Heteromer A5HZZ4; A5HZZ5; A5HZZ6; P09803; | 100 | 3×CA; | |||
| HA70(D3)-HA17 |
Heteromer Q45878; Q8KHU9; | 100 | ||||
| HA70(D3)-HA17-HA33 |
Heteromer Q45871; Q45878; Q8KHU9; | 100 | ||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4qd2.2.B | monomer | 0.90 | 100.00 | |||
| 1ybi.2.A | monomer | 0.51 | 26.23 | |||